Ignite Creation Date:
2024-07-17 @ 10:52 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06488664
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-05
First Post:
2024-06-28
Brief Title:
An Efficacy and Safety Study of GNR-068 Ustekinumab Biosimilar and Stelara in the Treatment of Patients With Moderate to Severe Plaque Psoriasis
Sponsor:
AO GENERIUM
Organization:
AO GENERIUM
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Plaque Psoriasis |
Keywords:
| Name | View |
|---|---|
| ustekinumab | View |
| humanized monoclonal antibodies | View |
| safety | View |
| plaque psoriasis | View |
| equivalence | View |
| biosimilar | View |
| PASI Psoriasis Area and Severity Index | View |
| BSA Body Surface Area | View |
| DLQI Dermatological Life Quality Index | View |
| PGA Physicians Global Assessment | View |
| immunogenicity | View |